ZS Pharma Receives $46,000,000 Series C Funding Round

  • Feed Type
  • Date
    10/26/2012
  • Company Name
    ZS Pharma
  • Mailing Address
    1120 South Freeway Fort Worth, TX 76104
  • Company Description
    Founded in 2008, ZS Pharma, Inc. is a privately held specialty pharmaceutical company located inFort Worth, Texas. It is focused on the development and commercialization of proprietary oral sorbent technology that will significantly improve the clinical outcomes of those patients suffering from toxic conditions associated with kidney and liver disease.
  • Website
    http://www.zspharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $46,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The funding will allow ZS Pharma to proceed with pivotal trials for ZS-9 as it prepares for commercialization of the product.
  • M&A Terms
  • Venture Investor
    Alta Partners
  • Venture Investor
    RiverVest Venture Partners
  • Venture Investor
    Devon Park Bioventures
  • Venture Investor
    3×5 Special Opportunity Partners
  • Venture Investor
    Salem Partners

By posting a comment, you agree to our terms and conditions.